Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia

NCT02329301 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2430

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Malaria, Falciparum

Interventions

DRUG: MDA with DHAp (Eurartesim)
DRUG: Focal MDA with DHAp (Eurartesim)

Sponsor

PATH

Collaborators

[object Object]
[object Object]
[object Object]